Reporting an outbreak of Candida pelliculosa fungemia in a neonatal intensive care unit

Journal of Microbiology, Immunology and Infection

Volumn 46, Issue 6, 2013, Pages 456-462

  Lin, Hsiao Chuan ^a,b,c   Lin, Hsiang Yu ^c   Su, Bai Hong ^b,c   Ho, Mao Wang ^c   Ho, Cheng Mao ^c   Lee, Ching Yi ^c   Lin, Ming Hsia ^c   Hsieh, Hsin Yang ^c   Lin, Hung Chih ^c   Li, Tsai Chung ^a   Hwang, Kao Pin ^c   Lu, Jang Jih ^a,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Candida pelliculosa; Fungemia; Neonatal intensive care unit; Outbreak; Preterm

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; MEROPENEM; MICAFUNGIN; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BREAST MILK; BROTH DILUTION; CAREGIVER; CHEMOPROPHYLAXIS; CHILDHOOD MORTALITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENVIRONMENTAL FACTOR; EPIDEMIC; EXTREMELY LOW BIRTH WEIGHT; FEMALE; FUNGAL STRAIN; FUNGEMIA; FUNGUS CULTURE; FUNGUS ISOLATION; GENETIC ANALYSIS; HAND WASHING; HOSPITALIZED INFANT; HUMAN; IN VITRO STUDY; INFANT; INFECTION CONTROL; INFECTION PREVENTION; MALE; NEWBORN; NEWBORN INTENSIVE CARE; NONHUMAN; NURSE; PATIENT CARE; PHYSICIAN; PICHIA ANOMALA; RANDOM AMPLIFIED POLYMORPHIC DNA; TERTIARY HEALTH CARE; THROMBOCYTOPENIA;

CANDIDA PELLICULOSA; FUNGEMIA; NEONATAL INTENSIVE CARE UNIT; OUTBREAK; PRETERM;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; DISEASE OUTBREAKS; FEMALE; FLUCONAZOLE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; INFECTION CONTROL; INTENSIVE CARE UNITS, NEONATAL; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MYCOLOGICAL TYPING TECHNIQUES; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TREATMENT OUTCOME;

EID: 84890114769     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.07.013     Document Type: Article

References (35)

1. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110:285-291.
2. Kaufman D., Boyle R., Hazen K.C., Patrie J.T., Robinson M., Donowitz L.G. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001, 345:1660-1666.
3. Kaufman D. Strategies for prevention of neonatal invasive candidiasis. Semin Perinatol 2003, 27:414-424.
4. Richardson M.D. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 2005, 56(Suppl. 1):i5-i11.
5. Ho T.S., Wang S.M., Wu Y.H., Shen C.F., Lin Y.J., Lin C.H., et al. Long-term characteristics of healthcare-associated infections in a neonatal intensive care unit. J Microbiol Immunol Infect 2010, 43:407-415.
6. Manzoni P., Arisio R., Mostert M., Leonessa M., Farina D., Latino M.A., et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics 2006, 117:e22-e32.
7. Murphy N., Buchanan C.R., Damjanovic V., Whitaker R., Hart C.A., Cooke R.W. Infection and colonisation of neonates by Hansenula anomala. Lancet 1986, 1:291-293.
8. Paula C.R., Krebs V.L., Auler M.E., Ruiz L.S., Matsumoto F.E., Silva E.H., et al. Nosocomial infection in newborns by Pichia anomala in a Brazilian intensive care unit. Med Mycol 2006, 44:479-484.
9. Klein A.S., Tortora G.T., Malowitz R., Greene W.H. Hansenula anomala: a new fungal pathogen. Two case reports anda review of the literature. Arch Intern Med 1988, 148:1210-1213.
10. Bakir M., Cerikcioǧlu N., Tirtir A., Berrak S., Ozek E., Canpolat C. Pichia anomala fungaemia in immunocompromised children. Mycoses 2004, 47:231-235.
11. Haron E., Anaissie E., Dumphy F., McCredie K., Fainstein V. Hansenula anomala fungemia. Rev Infect Dis 1988, 10:1182-1186.
12. Chakrabarti A., Singh K., Narang A., Singhi S., Batra R., Rao K.L., et al. Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India. J Clin Microbiol 2001, 39:1702-1706.
13. Sekhon A.S., Kowalewska-Grochowska K., Garg A.K., Vaudry W. Hansenula anomala fungemia in an infant with gastric and cardiac complications with a review of the literature. Eur J Epidemiol 1992, 8:305-308.
14. Kalenic S., Jandrlic M., Vegar V., Zuech N., Sekulic A., Mlinaric-Missoni E. Hansenula anomala outbreak at a surgical intensive care unit: a search for risk factors. Eur J Epidemiol 2001, 17:491-496.
15. Aragão P.A., Oshiro I.C., Manrique E.I., Gomes C.C., Matsuo L.L., Leone C., et al. Pichia anomala outbreak in a nursery: exogenous source?. Pediatr Infect Dis J 2001, 20:843-848.
16. Pasqualotto A.C., Sukiennik T.C., Severo L.C., de Amorim C.S., Colombo A.L. An outbreak of Pichia anomala fungemia in a Brazilian pediatric intensive care unit. Infect Control Hosp Epidemiol 2005, 26:553-558.
17. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard-Third Edition 2008, CLSI, CLSI document M27-A3, Clinical and Laboratory Standards Institute, Wayne, PA.
18. Pfaller M.A., Diekema D.J., Messer S.A., Boyken L., Hollis R.J., Jones R.N. Invitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Diagn Microbiol Infect Dis 2004, 48:101-105.
19. Nguyen M.H., Clancy C.J., Yu V.L., Yu Y.C., Morris A.J., Snydman D.R., et al. Do invitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. J Infect Dis 1998, 177:425-430.
20. Reference Method for Broth Dilution Antigungal Susceptibility Testing of Yeasts; Third Informational Supplement 2008, CLSI, CLSI document M27-S3, Clinical and Laboratory Standards Institute, Wayne, PA.
21. Baleiras Couto M.M., Eijsma B., Hofstra H., Huis In't Veld J.H., Van Der Vossen J.M. Evaluation of molecular typing techniques to assign genetic diversity among Saccharomyces cerevisiae strains. Appl Environ Microbiol 1996, 62:41-46.
22. Rønnestad A., Abrahamsen T.G., Medbø S., Reigstad H., Lossius K., Kaaresen P.I., et al. Late-onset septicemia in a Norwegian national cohort of extremely premature infants receiving very early full human milk feeding. Pediatrics 2005, 115:e269-e276.
23. López Sastre J.B., Coto Cotallo G.D., Fernández Colomer B. Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatol 2003, 20:153-163.
24. Zaoutis T.E., Greves H.M., Lautenbach E., Bilker W.B., Coffin S.E. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J 2004, 23:635-641.
25. da Matta V.L., de Souza Carvalho Melhem M., Colombo A.L., Moretti M.L., Rodero L., Duboc de Almeida G.M., et al. Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia. Antimicrob Agents Chemother 2007, 51:1573-1576.
26. Bhardwaj S., Sutar R., Bachhawat A.K., Singhi S., Chakrabarti A. PCR-based identification and strain typing of Pichia anomala using the ribosomal intergenic spacer region IGS1. J Med Microbiol 2007, 56:185-189.
27. Thuler L.C., Faivichenco S., Velasco E., Martins C.A., Nascimento C.R., Castilho I.A. Fungaemia caused by Hansenula anomala-an outbreak in a cancer hospital. Mycoses 1997, 40:193-196.
28. Moses A., Maayan S., Shvil Y., Dudin A., Ariel I., Thalji A., et al. Hansenula anomala infections in children: from asymptomatic colonization to tissue invasion. Pediatr Infect Dis J 1991, 10:400-402.
29. Neumeister B., Rockemann M., Marre R. Fungaemia due to Candida pelliculosa in a case of acute pancreatitis. Mycoses 1992, 35:309-310.
30. Lai C.C., Gau S.J., Tan C.K. Distribution of Candida species causing bloodstream infections. J Microbiol Immunol Infect 2012, 45:161-162.
31. Wong A.R., Ibrahim H., Van Rostenberghe H., Ishak Z., Radzi M.J. Hansenula anomala infection in a neonate. J Paediatr Child Health 2000, 36:609-610.
32. Barchiesi F., Tortorano A.M., Di Francesco L.F., Rigoni A., Giacometti A., Spreghini E., et al. Genotypic variation and antifungal susceptibilities of Candida pelliculosa clinical isolates. J Med Microbiol 2005, 54:279-285.
33. Krcmery V., Oravcova E., Spanik S., Mrazova-Studena M., Trupl J., Kunova A., et al. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. J Antimicrob Chemother 1998, 41:373-380.
34. Benjamin D.K., Smith P.B., Arrieta A., Castro L., Sánchez P.J., Kaufman D., et al. Safety and pharmacokinetics of repeat-dose micafungin in young infants. Clin Pharmacol Ther 2010, 87:93-99.
35. Guida J.D., Kunig A.M., Leef K.H., McKenzie S.E., Paul D.A. Platelet count and sepsis in very low birth weight neonates: is there an organism-specific response?. Pediatrics 2003, 111:1411-1415.